These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Induced pluripotent stem cells for regenerative cardiovascular therapies and biomedical discovery. Nsair A; MacLellan WR Adv Drug Deliv Rev; 2011 Apr; 63(4-5):324-30. PubMed ID: 21371511 [TBL] [Abstract][Full Text] [Related]
29. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors. Löhle M; Hermann A; Glass H; Kempe A; Schwarz SC; Kim JB; Poulet C; Ravens U; Schwarz J; Schöler HR; Storch A Stem Cells; 2012 Mar; 30(3):570-9. PubMed ID: 22213586 [TBL] [Abstract][Full Text] [Related]
30. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Takebe T; Sekine K; Enomura M; Koike H; Kimura M; Ogaeri T; Zhang RR; Ueno Y; Zheng YW; Koike N; Aoyama S; Adachi Y; Taniguchi H Nature; 2013 Jul; 499(7459):481-4. PubMed ID: 23823721 [TBL] [Abstract][Full Text] [Related]
31. Regulation of endothelial cell differentiation in embryonic vascular development and its therapeutic potential in cardiovascular diseases. Guo Z; Mo Z Life Sci; 2021 Jul; 276():119406. PubMed ID: 33785330 [TBL] [Abstract][Full Text] [Related]
32. Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells. Jia B; Chen S; Zhao Z; Liu P; Cai J; Qin D; Du J; Wu C; Chen Q; Cai X; Zhang H; Yu Y; Pei D; Zhong M; Pan G Life Sci; 2014 Jul; 108(1):22-9. PubMed ID: 24834837 [TBL] [Abstract][Full Text] [Related]
33. Derivation of endothelial cells from porcine induced pluripotent stem cells by optimized single layer culture system. Wei R; Lv J; Li X; Li Y; Xu Q; Jin J; Zhang Y; Liu Z J Vet Sci; 2020 Jan; 21(1):e9. PubMed ID: 31940688 [TBL] [Abstract][Full Text] [Related]
34. Therapeutic potential of human-induced pluripotent stem cell-derived endothelial cells in a bleomycin-induced scleroderma mouse model. Azhdari M; Baghaban-Eslaminejad M; Baharvand H; Aghdami N Stem Cell Res; 2013 May; 10(3):288-300. PubMed ID: 23396195 [TBL] [Abstract][Full Text] [Related]
35. Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins. Rowland TJ; Blaschke AJ; Buchholz DE; Hikita ST; Johnson LV; Clegg DO J Tissue Eng Regen Med; 2013 Aug; 7(8):642-53. PubMed ID: 22514096 [TBL] [Abstract][Full Text] [Related]
36. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine. Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424 [TBL] [Abstract][Full Text] [Related]
37. Being human: The role of pluripotent stem cells in regenerative medicine and humanizing Alzheimer's disease models. Sproul AA Mol Aspects Med; 2015; 43-44():54-65. PubMed ID: 26101165 [TBL] [Abstract][Full Text] [Related]
38. Induced pluripotent stem cells in regenerative medicine and disease modeling. Walmsley GG; Hyun J; McArdle A; Senarath-Yapa K; Hu MS; Chung MT; Wong VW; Longaker MT; Wan DC Curr Stem Cell Res Ther; 2014 Mar; 9(2):73-81. PubMed ID: 24359141 [TBL] [Abstract][Full Text] [Related]
39. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology. Liu Y; Deng W Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934 [TBL] [Abstract][Full Text] [Related]